Today Mellanox announced that the HPC4Health Consortium, led by The Hospital for Sick Children (SickKids) and the University Health Network’s Princess Margaret Cancer Centre, has selected its InfiniBand networking solutions to improve patient care and help researchers to optimize treatment with the ultimate goal of finding a cure for cancer. The end-to-end FDR 56Gb/s InfiniBand networking solution was adopted as the foundation of the center’s cancer and genomics program, to accelerate the sharing, processing and analysis of data generated from radiology imaging, medical imaging analysis, protein folding, x-ray diffraction in order to improve patient care and expedite cancer research.
The amount of data created by today’s biomedical research environments requires computing architectures that are extremely fast, flexible and scalable,” said Jorge Gonzalez-Outeirino, technical manager and HPC4Health assistant director. “Mellanox’s CloudX and InfiniBand technology will facilitate collaboration between researchers and clinicians by enabling research to be shared. Our goal is to accelerate diagnoses and provide more personalized healthcare services for our patients.”
HPC4Health has deployed Mellanox CloudX to connect the individual clouds hosted by SickKids and the Princess Margaret Cancer Centre to consolidate resources, minimize maintenance and operational costs, and improve the utilization of computational resources. Mellanox’s end-to-end FDR 56Gb/s InfiniBand solution provides high-bandwidth and a low-latency processing framework needed for the internal data network to link with the two private clouds.
“Mellanox has offered support in the technical orchestration of the cluster,” said Carl Virtanen, HPC4health associate director and manager of bioinformatics services for the Princess Margaret Cancer Centre. “They have been hands-on and available to address any questions or concerns we have had with the implementation of these sophisticated computing models. Since working with Mellanox, we have seen dramatic increases in application speed and efficiency of our virtualized networks.”
“Mellanox’s complete end-to-end FDR 56Gb/s InfiniBand solutions provide the industry-leading processing throughput and bandwidth requirements needed to handle the immense computational demands being placed on today’s healthcare data centers,” said Kevin Deierling, vice president of marketing at Mellanox Technologies. “Mellanox is proud to be a part of such a noble mission to enable collaboration between researchers and clinicians to drive cutting edge advances in biomedical research, which will ultimately improve and save lives.”
Download the insideHPC Guide to Genomics.